[狂犬病和流动性:2025年更新]
Alexia Anagnostopoulos1,2, Anita Niederer-Loher3, Daniela Hüssy4,5
1Zentrum für Reisemedizin der Universität Zürich, Departement Public Global Health, Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich | WHO Collaborating Centre for Travellers' Health, Zürich.
Praxis
|December 19, 2024
概括
尽管瑞士已经没有狂犬病20年,但狂犬病仍然是瑞士的一个问题. 疫苗需求增加和供应短缺给狂犬病预防和控制带来了挑战.
科学领域:
- 兽医公共卫生 兽医公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 20多年来,瑞士一直保持着陆地狂犬病免费的地位.
- 尽管如此,狂犬病和疫苗接种仍然非常重要,因为人类和动物的流动性增加了.
- 该研究解决了一些挑战,包括疫苗需求的增加和反复出现的供应短缺.
研究的目的:
- 突出瑞士狂犬病预防的关键考虑因素.
- 讨论增加流动性对疾病传播的影响.
- 为应对疫苗供应链问题所带来的挑战.
主要方法:
- 瑞士当前狂犬病流行病学和控制策略的审查.
- 分析导致疫苗需求增加的因素.
- 检查疫苗供应链漏洞的情况.
主要成果:
- 20多年来,瑞士没有陆地狂犬病.
- 人类和动物旅行的全球增加增加狂犬病风险.
- 疫苗短缺对正在进行的狂犬病预防工作构成重大威胁.
结论:
- 保持无狂犬病的地位需要持续的警和适应.
- 解决疫苗供应链性问题对于公众和动物健康至关重要.
- 需要积极的战略来管理狂犬病预防的不断变化的挑战.
更多相关视频
07:40Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
13.3K
10:26Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings
Published on: August 18, 2023
5.0K
相关概念视频
01:24Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
01:15Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476